Matches in Wikidata for { <http://www.wikidata.org/entity/Q51643519> ?p ?o ?g. }
- Q51643519 description "2016 nî lūn-bûn" @default.
- Q51643519 description "2016年の論文" @default.
- Q51643519 description "2016年学术文章" @default.
- Q51643519 description "2016年学术文章" @default.
- Q51643519 description "2016年学术文章" @default.
- Q51643519 description "2016年学术文章" @default.
- Q51643519 description "2016年学术文章" @default.
- Q51643519 description "2016年学术文章" @default.
- Q51643519 description "2016年學術文章" @default.
- Q51643519 description "2016年學術文章" @default.
- Q51643519 description "2016年學術文章" @default.
- Q51643519 description "2016年學術文章" @default.
- Q51643519 description "2016年學術文章" @default.
- Q51643519 description "2016년 논문" @default.
- Q51643519 description "article científic" @default.
- Q51643519 description "article scientific" @default.
- Q51643519 description "article scientifique" @default.
- Q51643519 description "articol științific" @default.
- Q51643519 description "articolo scientifico" @default.
- Q51643519 description "artigo científico" @default.
- Q51643519 description "artigo científico" @default.
- Q51643519 description "artigo científico" @default.
- Q51643519 description "artikel ilmiah" @default.
- Q51643519 description "artikull shkencor" @default.
- Q51643519 description "artikulong pang-agham" @default.
- Q51643519 description "artykuł naukowy" @default.
- Q51643519 description "artículo científico publicado en 2016" @default.
- Q51643519 description "artículu científicu" @default.
- Q51643519 description "bilimsel makale" @default.
- Q51643519 description "bài báo khoa học" @default.
- Q51643519 description "naučni članak" @default.
- Q51643519 description "scienca artikolo" @default.
- Q51643519 description "scientific article published on 14 July 2016" @default.
- Q51643519 description "scientific article published on 14 July 2016" @default.
- Q51643519 description "scientific article published on 14 July 2016" @default.
- Q51643519 description "teaduslik artikkel" @default.
- Q51643519 description "tieteellinen artikkeli" @default.
- Q51643519 description "tudományos cikk" @default.
- Q51643519 description "vedecký článok" @default.
- Q51643519 description "vetenskaplig artikel" @default.
- Q51643519 description "videnskabelig artikel" @default.
- Q51643519 description "vitenskapelig artikkel" @default.
- Q51643519 description "vitskapeleg artikkel" @default.
- Q51643519 description "vědecký článek" @default.
- Q51643519 description "wetenschappelijk artikel" @default.
- Q51643519 description "wissenschaftlicher Artikel" @default.
- Q51643519 description "επιστημονικό άρθρο" @default.
- Q51643519 description "мақолаи илмӣ" @default.
- Q51643519 description "наукова стаття, опублікована в липні 2016" @default.
- Q51643519 description "научна статия" @default.
- Q51643519 description "научная статья" @default.
- Q51643519 description "научни чланак" @default.
- Q51643519 description "научни чланак" @default.
- Q51643519 description "מאמר מדעי" @default.
- Q51643519 description "مقالة علمية نشرت في 14 يوليو 2016" @default.
- Q51643519 description "১৪ জুলাই ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q51643519 description "บทความทางวิทยาศาสตร์" @default.
- Q51643519 description "სამეცნიერო სტატია" @default.
- Q51643519 name "Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study." @default.
- Q51643519 name "Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study." @default.
- Q51643519 type Item @default.
- Q51643519 label "Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study." @default.
- Q51643519 label "Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study." @default.
- Q51643519 prefLabel "Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study." @default.
- Q51643519 prefLabel "Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study." @default.
- Q51643519 P1433 Q51643519-5DD8EBA5-6401-4E55-B587-4C0ED68D12B8 @default.
- Q51643519 P1476 Q51643519-20D57F0D-D59F-48ED-9DC3-E214F9D50FD2 @default.
- Q51643519 P2093 Q51643519-21AA3390-F317-4627-A06C-8C7A71C4973D @default.
- Q51643519 P2093 Q51643519-30F92733-70F9-42AD-9B5C-062F1062CF8B @default.
- Q51643519 P2093 Q51643519-32E47890-C702-4032-8348-4F3BB922A52B @default.
- Q51643519 P2093 Q51643519-34688C8B-ACC3-40B5-8475-03A8145A09F1 @default.
- Q51643519 P2093 Q51643519-58185261-D8F2-40AB-B87B-0048704E65EE @default.
- Q51643519 P2093 Q51643519-58847291-5F3C-4015-BB23-8DCAE4E43502 @default.
- Q51643519 P2093 Q51643519-5A63E850-4642-40A5-B2D1-79709D773CB4 @default.
- Q51643519 P2093 Q51643519-60FEE6F6-C073-4B7C-87A9-095C168102A6 @default.
- Q51643519 P2093 Q51643519-819EAF5F-22DE-46B5-B590-ACA5821593BB @default.
- Q51643519 P2093 Q51643519-8BC9A48F-FC72-42CE-915C-460AA784DA3E @default.
- Q51643519 P2093 Q51643519-A7CF7E27-850A-41B2-8A0A-F02A89A140B0 @default.
- Q51643519 P2860 Q51643519-0AF22B9F-0D9E-4A4D-886F-7481B7228266 @default.
- Q51643519 P2860 Q51643519-1BFF7E05-E991-45E5-8966-A4ACF4F4D70F @default.
- Q51643519 P2860 Q51643519-1C78412F-BAA3-4D00-A2E0-ABBD294BB942 @default.
- Q51643519 P2860 Q51643519-1D3CDFE2-5760-4AC7-83A1-8CEEE2DE7118 @default.
- Q51643519 P2860 Q51643519-25FC422C-59F5-4961-8FE8-38969AA755ED @default.
- Q51643519 P2860 Q51643519-26BF788D-5D71-456B-A701-EE752E05882F @default.
- Q51643519 P2860 Q51643519-2AE277DF-EEAE-4F18-B89C-9CC26CC93B62 @default.
- Q51643519 P2860 Q51643519-31BC86D7-0B7B-49FA-B72E-182B20F43BFC @default.
- Q51643519 P2860 Q51643519-4C011118-F5AD-4D28-8643-31EE8EE09D3D @default.
- Q51643519 P2860 Q51643519-4D979CAE-7C17-41DE-8A78-3738DB0AA538 @default.
- Q51643519 P2860 Q51643519-528D4DD7-8FF0-48E5-A9A9-AB56D0B39C47 @default.
- Q51643519 P2860 Q51643519-7885C921-4C32-4ED0-AB22-57DC123A429B @default.
- Q51643519 P2860 Q51643519-7A42D4DD-524E-4670-B84C-C532C27E886F @default.
- Q51643519 P2860 Q51643519-7BED4FD8-A492-4B78-9608-4E0E3173C42A @default.
- Q51643519 P2860 Q51643519-83FEA715-55CE-499A-9E16-E0FB71EBE254 @default.
- Q51643519 P2860 Q51643519-8FA71C1D-944C-4DA2-BF47-02121283239F @default.
- Q51643519 P2860 Q51643519-AB1AB472-FF11-4785-9275-004A198EC8C8 @default.
- Q51643519 P2860 Q51643519-B33C8DFB-CDA0-413A-87E8-4F6D334D3AD7 @default.
- Q51643519 P2860 Q51643519-C4D06117-5198-4682-AE85-4BF8C52DED0B @default.
- Q51643519 P2860 Q51643519-C7FDBCFD-5EB3-4255-A1AC-3964843A81D1 @default.
- Q51643519 P2860 Q51643519-D871E567-10E3-4D50-9A6F-04318E7AF4D0 @default.
- Q51643519 P2860 Q51643519-DBF87475-ADBA-45C9-B53B-81DAC8D9B08A @default.